KRAS and neoplasm: Intriguingly, increased Bak expression was observed in tumor tissues from KL mice as compared to adjacent normal lung tissues (Figure S6B), thereby providing a strong rationale to employ Bak agonist BKA-073 for the treatment of mutant KRAS-driven lung cancer.